TherapeuticsMD TXMD announced today the appointment of
Joel S. Krasnow, M.D., M.B.A., a leading board-certified OB/GYN and
reproductive endocrinologist with broad biotech and pharmaceutical
experience, as the Company's Chief Scientific Officer and head of its
regulatory department.
Dr. Krasnow's career spans 15 years in the pharmaceutical industry,
including several global product registrations in women's health and
related areas. He began his career in academic medicine where he
received funding for both basic science and clinical research in women's
health. During his time in academic medicine, Dr. Krasnow served as the
Principal Investigator on a number of menopause clinical trials
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in